Latest immunotherapy news
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population
posted January 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations Developed for Optimizing Biologics in Adults With Severe Asthma
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Prolonged With Sacituzumab Govitecan Plus Pembrolizumab in TNBC
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Related Articles
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Monthly Specialist Briefings
Stay Connected
